Intracellular signal transduction pathways activated by ceramide and its metabolites

Pharmacological Research

Volumn 47, Issue 5, 2003, Pages 383-392

  Ruvolo, Peter P ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Ceramide; PP2A; SAPK; Stress signal pathway

Indexed keywords

1 PHENYL 2 PALMITOYLAMINO 3 MORPHOLINO 1 PROPANOL; CD40 ANTIGEN; CELL DEATH RECEPTOR; CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR; DIACYLGLYCEROL; ENZYME; FENRETINIDE; ISOENZYME; JUN KINASE; KINASE SUPPRESSOR OF RAS; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN FAN; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE C ZETA; PROTEIN P55; PROTEIN P75; RAF PROTEIN; RECEPTOR; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER INHIBITION; CELL DEATH; CELL GROWTH; CELL SURVIVAL; CELLULAR DISTRIBUTION; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG RESPONSE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LOCALIZATION; GLYCOSYLATION; HUMAN; LIPID METABOLISM; METABOLITE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

EID: 0037401894     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(03)00050-1     Document Type: Review

References (127)

1. Kolesnick R.N., Goni F.M., Alonso A. Compartmentalization of ceramide signaling: physical foundations and biological effects. J. Cell. Physiol. 184:2000;285-300.
2. Smyth M.L., Obeid L.M., Hannun Y.A. Ceramide: a novel lipid mediator of apoptosis. Adv. Pharm. 41:1997;133-154.
3. Hannun Y.A. Functions of ceramide in coordinating cellular responses in stress. Science. 274:1996;1855-1859.
4. Ruvolo P.P. Ceramide regulates cellular homeostasis via diverse stress signaling pathways. Leukemia. 15:2001;1153-1160.
5. Hannun Y.A. The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem. 26:1994;3125-3128.
6. Kolesnick R.N., Kronke M. Regulation of ceramide production and apoptosis. Ann. Rev. Physiol. 60:1998;643-665.
7. Ruiz-Arguello M.B., Basanez G., Goni F.M., Alonso A. Different effects of enzyme-generated ceramides and diacylglycerols in phospholipid membrane fusion and leakage. J. Biol. Chem. 271:1996;26616-26621.
8. Siskind L.J., Colombini M. The lipids C2- and C16-ceramide form large stable channels. Implications for apoptosis. J. Biol. Chem. 275:2000;38640-38644.
9. Siskind L.J., Kolesnick R.N., Colombini M. Ceramide channels increase the permeability of the mitochondrial outer membrane to small proteins. J. Biol. Chem. 277:2002;26796-26803.
10. Montes L.R., Ruiz-Arguello M.B., Goni F.M., Alonso A. Membrane restructuring via ceramide results in enhanced solute efflux. J. Biol. Chem. 277:2002;11788-11794.
11. Jarvis W.D., Grant S., Kolesnick R.N. Ceramide and the induction of apoptosis. Clin. Cancer Res. 2:1996;1-6.
12. Basu S., Kolesnick R. Stress signals for apoptosis: ceramide and c-jun kinase. Oncogene. 17:1998;3277-3285.
13. Kolesnick R.N., Kronke M. Regulation of ceramide production and apoptosis. Ann. Rev. Physiol. 60:1998;643-645.
14. Kolesnick R., Hannun Y.A. Ceramide and apoptosis. Trends Biochem. Sci. 24:1999;224-225.
15. Hannun Y.A., Luberto C. Ceramide in the eukaryotic stress response. Trends Cell Biol. 10:2000;73-80.
16. Verheij M., Bose R., Lin X.H., Yao B., Jarvis W.D., Grant S.et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 380:1996;75-79.
17. Kyriakis J.M., Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271:1996;24313-24316.
18. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F.et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 369:1994;156-160.
19. Jarvis W.D., Fornari F.A., Auer K.L., Freemerman A.J., Szabo E., Birrer M.J.et al. Coordinate regulation of stress- and mitogen-activated protein kinases in the apoptotic actions of ceramide and sphingosine. Mol. Pharmacol. 52:1997;935-947.
20. Bourbon N.A., Yun J., Kester M. Ceramide directly activates protein kinase C ζ to regulate a stress-activated protein kinase signaling complex. J. Biol. Chem. 275:2000;35617-35623.
21. Dobrowsky R.T., Hannun Y.A. Ceramide stimulates a cytosolic protein phosphatase 2A. J. Biol. Chem. 267:1992;5048-5051.
22. Dobrowsky R.T., Kamibayasha C., Mumby M.C., Hannun Y.A. Ceramide activates a heterotrimeric protein phosphatase 2A. J. Biol. Chem. 268:1993;15523-15530.
23. Ruvolo P.P., Deng X., Ito T., Carr B.K., May W.S. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J. Biol. Chem. 274:1999;20296-20300.
24. Chalfant C.E., Kishikawa K., Mumby M.C., Kamibayashi C., Bielawska A., Hannun Y.A. Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid. J. Biol. Chem. 274:1999;20313-20317.
25. Lee J.Y., Hannun Y.A., Obeid L.M. Ceramide inactivates cellular protein kinase C alpha. J. Biol. Chem. 271:1996;13169-13174.
26. Lee J.Y., Hannun Y.A., Obeid L.M. Functional dichotomy of protein kinase C (PKC) in tumor necrosis factor-alpha (TNF-alpha) signal transduction in L929 cells. Translocation and inactivation of PKC by TNF-alpha. J. Biol. Chem. 275:2000;29290-29298.
27. Schubert K.M., Scheid M.P., Duronio V. Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473. J. Biol. Chem. 275:2000;13330-13335.
28. Salinas M., Lopez-Valdaliso R., Martin D., Alvarez A., Cuadrado A. Inhibition of PKB/Akt1 by C2-ceramide involves activation of ceramide-activated protein phosphatase in PC12 cells. Mol. Cell Neurosci. 15:2000;156-169.
29. Ruvolo P.P., Clark W., Mumby M., Gao F., May W.S. A functional role for the B56 alpha-subunit of protein phosphatase 2A in ceramide-mediated regulation of Bcl2 phosphorylation status and function. J. Biol. Chem. 277:2002;22847-22852.
30. Senchenkov A., Litvak D.A., Cabot M.C. Targeting ceramide metabolism - a strategy for overcoming drug resistance. J. Natl. Cancer Inst. 93:2001;347-357.
31. Cai Z., Bettaieb A., Mahdani N.E., Legres L.G., Stancou R., Masliah J.et al. Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF7 cells to tumor necrosis factor-alpha-mediated cytotoxicity. J. Biol. Chem. 272:1997;6918-6926.
32. Liu Y.Y., Han T.Y., Giuliano A.E., Cabot M.C. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J. Biol. Chem. 274:1999;1140-1146.
33. Liu Y.Y., Han T.Y., Giuliano A.E., Hansen N., Cabot M.C. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J. Biol. Chem. 275:2000;7138-7143.
34. Michael J.M., Lavin M.F., Watters D.J. Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling. Cancer Res. 57:1997;3600-3605.
35. Maurer B.J., Melton L., Billups C., Cabot M.C., Reynolds C.P. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism. J. Natl. Cancer Inst. 92:2000;1897-1909.
36. Kolesnick R. The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J. Clin. Invest. 110:2002;3-8.
37. Zhang H., Buckley N.E., Gibson K., Spiegel S. Sphingosine stimulates cellular proliferation via a protein kinase C-independent pathway. J. Biol. Chem. 265:1990;76-81.
38. Spiegel S., Milstien S. Sphingosine-1-phosphate: signaling inside and out. FEBS Lett. 476:2000;55-57.
39. Cuvillier O., Pirianov G., Kleuser B., Vanek P.G., Coso O.A., Gutkind S.et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature. 381:1996;800-803.
40. Spiegel S., Kolesnick R. Sphingosine 1-phosphate as a therapeutic agent. Leukemia. 16:2002;1596-1602.
41. Birbes H., El Bawab S., Hannun Y.A., Obeid L.M. Selective hydrolysis of a mitochondrial pool of sphingomyelin induces apoptosis. FASEB J. 15:2001;2669-2679.
42. Kronke M. Involvement of sphingomyelinases in TNF signaling pathways. Chem. Phys. Lipids. 102:1999;157-166.
43. Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Kovalenko A.V., Boldin M.P. Tumor necrosis factor receptor and Fas signaling mechanisms. Ann. Rev. Immunol. 17:1999;331-367.
44. Adam D., Wiegmann K., Adam-Klages S., Ruff A., Kronke M. A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. J. Biol. Chem. 271:1996;14617-14622.
45. Wiegmann K., Schutze S., Machleidt T., Witte D., Kronke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell. 78:1994;1005-1015.
46. Adam-Klages S., Adam D., Wiegmann K., Struve S., Kolanus W., Schneider-Mergener J.et al. FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell. 86:1996;937-947.
47. Kolesnick R.N., Goni F.M., Alonso A. Compartmentalization of ceramide signaling: physical foundations and biological effects. J. Cell. Physiol. 184:2000;285-300.
48. Dobrowsky R.T. Sphingolipid signalling domains floating on rafts or buried in caves? Cell Signal. 12:2000;81-90.
49. Anderson R.G., Jacobson K. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science. 296:2002;1821-1825.
50. Bilderback T.R., Gazula V.R., Dobrowsky R.T. Phosphoinositide 3-kinase regulates crosstalk between Trk A tyrosine kinase and p75(NTR)-dependent sphingolipid signaling pathways. J. Neurochem. 76:2001;1540-5151.
51. Grassme H., Jendrossek V., Bock J., Riehle A., Gulbins E. Ceramide-rich membrane rafts mediate CD40 clustering. J. Immunol. 168:2002;298-307.
52. Zundel W., Giaccia A. Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress. Genes Dev. 12:1998;1941-1946.
53. Jarvis W.D., Fornari F.A., Browning J.L., Gewirtz D.A., Kolesnick R.N., Grant S. Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J. Biol. Chem. 269:1994;31685-31692.
54. Luberto C., Hannun Y.A. Sphingomyelin synthetase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. J. Biol. Chem. 273:1998;14550-14559.
55. Chmura S.J., Nodzenski E., Weichselbaum R.R., Quintans J. Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase. Cancer Res. 56:1996;2711-2714.
56. Spiegel S., Merrill A.H. Sphingolipid metabolism and cell growth regulation. FASEB J. 10:1996;1388-1397.
57. Ohta H., Sweeney E.A., Masamune A., Yatomi Y., Hakomori S., Igarashi Y. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res. 55:1995;691-697.
58. Jarvis W.D., Fornari F.A., Traylor R.S., Martin H.A., Kramer L.B., Erukulla R.K.et al. Induction of apoptosis and potentiation of ceramide-mediated cytotoxicity by sphingoid bases in human myeloid leukemia cells. J. Biol. Chem. 271:1996;8275-8284.
59. Nava V.E., Cuvillier O., Edsall L.C., Kimura K., Milstien S., Gelmann E.P.et al. Sphingosine enhances apoptosis of radiation-resistant prostate cancer cells. Cancer Res. 60:2000;4468-4474.
60. Stevens V.L., Nimkar S., Jamison W.C., Liotta D.C., Merrill A.H. Characteristics of the growth inhibition and cytotoxicity of long-chain (sphingoid) bases for Chinese hamster ovary cells: evidence for an involvement of protein kinase C. Biochim. Biophys. Acta. 1051:1990;37-45.
61. Coroneos E., Wang Y., Panuska J.R., Templeton D.J., Kester M. Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascades. Biochem. J. 316(Pt 1):1996;13-17.
62. Brenner B., Koppenhoefer U., Weinstock C., Linderkamp O., Lang F., Gulbins E. Fas- or ceramide-induced apoptosis is mediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J. Biol. Chem. 272:1997;22173-22181.
63. Lozano J., Berra E., Municio M.M., Diaz-Meco M.T., Dominguez I., Sanz L.et al. Protein kinase C zeta isoform is critical for kappa B-dependent promoter activation by sphingomyelinase. J. Biol. Chem. 269:1994;19200-19202.
64. Derijard B., Hibi M., Wu I.H., Barrett T., Su B., Deng T.et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 76:1994;1025-1037.
65. Shirakabe K., Yamaguchi K., Shibuya H., Irie K., Matsuda S., Moriguchi T.et al. TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J. Biol. Chem. 272:1997;8141-8144.
66. Sawai H., Okazaki T., Yamamoto H., Okano H., Takeda Y., Tashima M.et al. Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J. Biol. Chem. 270:1995;27326-27331.
67. Maundrell K., Antonsson B., Magnenat E., Camps M., Muda M., Chabert C.et al. Bcl2 undergoes phosphorylation by c-Jun N-terminal/stress-activated protein kinase in the presence of constitutively active GTP binding protein Rac-1. J. Biol. Chem. 272:1997;25238-25242.
68. Haldar S., Basu A., Croce C.M. Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. Cancer Res. 58:1998;1609-1615.
69. Yamamoto K., Ihijo H., Korsmeyer S. Bcl2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G2/M. Mol. Cell Biol. 19:1999;8469-8478.
70. Mechta-Grigoriou F., Gerald D., Yaniv M. The mammalian Jun proteins: redundancy and specificity. Oncogene. 20:2001;2378-2389.
71. Watson A., Eilers A., Lallemand D., Kyriakis J., Rubin L.L., Ham J. Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons. J. Neurosci. 18:1998;751-762.
72. Muller G., Ayoub M., Storz P., Rennecke J., Fabbro D., Pfizenmaier K. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14:1995;1961-1969.
73. Procyk K.J., Rippo M.R., Testi R., Hofmann F., Parker P.J., Baccarini M. Lipopolysaccharide induces jun N-terminal kinase activation in macrophages by a novel Cdc42/Rac-independent pathway involving sequential activation of protein kinase C zeta and phosphatidylcholine-dependent phospholipase C. Blood. 96:2000;2592-2598.
74. Doornbos R.P., Theelen M., van der Hoeven P.C., van Blitterswijk W.J., Verkleij A.J., van Bergen en Henegouwen P.M. Protein kinase C zeta is a negative regulator of protein kinase B activity. J. Biol. Chem. 274:1999;8589-8596.
75. del Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science. 278:1997;687-689.
76. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y.et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241.
77. Hurley J.H., Newton A.C., Parker P.J., Blumberg P.M., Nishizuka Y. Taxonomy and function of C1 protein kinase C homology domains. Protein Sci. 6:1997;477-480.
78. Uberall F., Hellbert K., Kampfer S., Maly K., Villunger A., Spitaler M.et al. Evidence that atypical protein kinase C-lambda and atypical protein kinase C-zeta participate in Ras-mediated reorganization of the F-actin cytoskeleton. J. Cell Biol. 144:1999;413-425.
79. Joseph C.K., Byun H.S., Bittman R., Kolesnick R.N. Substrate recognition by ceramide-activated protein kinase. Evidence that kinase activity is proline-directed. J. Biol. Chem. 268:1993;20002-20006.
80. Liu J., Mathias S., Yang Z., Kolesnick R.N. Renaturation and tumor necrosis factor-alpha stimulation of a 97-kDa ceramide-activated protein kinase. J. Biol. Chem. 269:1994;3047-3052.
81. Mathias S., Dressler K.A., Kolesnick R.N. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor alpha. Proc. Natl. Acad. Sci. U.S.A. 88:1991;10009-10013.
82. Zhang Y., Yao B., Delikat S., Bayoumy S., Lin X.H., Basu S.et al. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell. 89:1997;63-72.
83. Basu S., Bayoumy S., Zhang Y., Lozano J., Kolesnick R. BAD enables ceramide to signal apoptosis via Ras and Raf-1. J. Biol. Chem. 273:1998;30419-30426.
84. Yan F., Polk D.B. Kinase suppressor of ras is necessary for tumor necrosis factor alpha activation of extracellular signal-regulated kinase/mitogen-activated protein kinase in intestinal epithelial cells. Cancer Res. 61:2001;963-969.
85. Huwiler A., Brunner J., Hummel R., Vervoordeldonk M., Stabel S., van den Bosch H.et al. Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6959-6963.
86. Michaud N.R., Therrien M., Cacace A., Edsall L.C., Spiegel S., Rubin G.M.et al. KSR stimulates Raf-1 activity in a kinase-independent manner. Proc. Natl. Acad. Sci. U.S.A. 94:1997;12792-12796.
87. Zhou M., Horita D.A., Waugh D.S., Byrd R.A., Morrison D.K. Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR). J. Mol. Biol. 315:2002;435-446.
88. Therrien M., Chang H.C., Solomon N.M., Karim F.D., Wassarman D.A., Rubin G.M. KSR, a novel protein kinase required for RAS signal transduction. Cell. 83:1995;879-888.
89. Ruvolo P.P., Gao F., Blalock W.L., Deng X., May W.S. Ceramide Regulates Protein Synthesis By A Novel Mechanism Involving The Cellular PKR Activator RAX. J. Biol. Chem. 276:2001;11754-11765.
90. Clemens M.J., Elia A. The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17:1997;503-524.
91. Tan S.L., Katze M.G. The emerging role of the interferon-induced PKR protein kinase as an apoptotic effector: a new face of death? J. Interferon Cytokine Res. 19:1999;543-554.
92. Williams B.R.G. PKR, A sentinel kinase for cellular stress. Oncogene. 18:1999;6112-6120.
93. Ito T., Jagus R., May W.S. Interleukin-3 stimulates protein synthesis by regulating double-stranded RNA-dependent protein kinase (PKR) in a novel cytokine signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 91:1994;7455-7459.
94. Scheid M.P., Foltz I.N., Young P.R., Schrader J.W., Duronio V. Ceramide and cyclic adenosine monophosphate (cAMP) induce cAMP response element binding protein phosphorylation via distinct signaling pathways while having opposite effects on myeloid cell survival. Blood. 93:1999;217-225.
95. Gulbins E., Coggeshall K.M., Baier G., Telford D., Langlet C., Baier-Bitterlich G.et al. Direct stimulation of Vav guanine nucleotide exchange activity for Ras by phorbol esters and diglycerides. Mol. Cell Biol. 14:1994;4749-4758.
96. Esteve P., Embade N., Perona R., Jimenez B., del Peso L., Leon J.et al. Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl2 dependent pathway. Oncogene. 17:1998;1855-1869.
97. Chiang C.-W., Harris G., Ellig C., Masters S.C., Subramanian R., Shenolikar S.et al. Protein phosphatase 2A activates the proapoptotic function of BAD in interleukin-3-dependent lymphoid cells by a mechanism requiring 14-3-3 dissociation. Blood. 97:2001;1289-1297.
98. Mumby M.C., Walter G. Protein serine/threonine phosphatases: structure regulation and function in cell growth. Physiol. Rev. 73:1993;673-699.
99. Mayer-Jaekel R.E., Baumgartner S., Bilbe G., Ohkura H., Glover D.M., Hemmings B.A. Molecular cloning and developmental expression of the catalytic and 65kd regulatory subunits of protein phosphatase 2A in Drosophilia. Mol. Biol. Cell. 3:1992;287-298.
100. Mayer R.E., Hendrix P., Cron P., Matthies R., Stone S.R., Goris J.et al. Structure of the 55kd subunit of protein phosphatase 2A: evidence for neuronal-specific isoform. Biochemistry. 30:1991;3589-3597.
101. 0. J. Biol. Chem. 271:1996;2578-2588.
102. Cegielska A., Shaffer S., Derua R., Goris J., Virshup D.M. Different oligomeric forms of protein phosphatase 2A activate and inhibit simian virus 40 DNA replication. Mol. Cell Biol. 14:1994;4616-4623.
103. Sontag E., Nunbhakdi-Craig V., Bloom G.S., Mumby M.C. A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J. Cell Biol. 128:1995;1131-1144.
104. McCright B., Rivers A.M., Audlin S., Virshup D.M. The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. J. Biol. Chem. 271:1996;22081-22089.
105. Xu Z., Williams B.R. The B56 alpha regulatory subunit of protein phosphatase 2A is a target for regulation by double-stranded RNA-dependent protein kinase PKR. Mol. Cell Biol. 20:2000;5285-5299.
106. Williams B.R. Signal integration via PKR. Sci. STKE. 2001:2001;RE2.
107. Dbaibo G.S., Pushkareva M.Y., Jayadev S., Schwarz J.K., Horowitz J.M., Obeid L.M.et al. Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc. Natl. Acad. Sci. U.S.A. 92:1995;1347-1351.
108. Kishikawa K., Chalfant C.E., Perry D.K., Bielawska A., Hannun Y.A. Phosphatidic acid is a potent and selective inhibitor of protein phosphatase 1 and an inhibitor of ceramide-mediated responses. J. Biol. Chem. 274:1999;21335-21341.
109. Chalfant C.E., Ogretmen B., Galadari S., Kroesen B.J., Pettus B.J., Hannun Y.A. FAS activation induces dephosphorylation of SR proteins dependence on the de novo generation of ceramide and activation of protein phosphatase 1a. J. Biol. Chem. 276:2001;44848-44855.
110. Chalfant C.E., Rathman K., Pinkerman R.L., Wood R.E., Obeid L.M., Ogretmen B.et al. de novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells Dependence on protein phosphatase-1. J. Biol. Chem. 277:2002;12587-12595.
111. Zahler A.M., Lane W.S., Stolk J.A., Roth M.B. SR proteins: a conserved family of pre-mRNA splicing factors. Genes Dev. 6:1992;837-847.
112. Zahler A.M., Neugebauer K.M., Lane W.S., Roth M.B. Distinct functions of SR proteins in alternative pre-mRNA splicing. Science. 260:1993;219-222.
113. Misteli T., Spector D.L. Serine/threonine phosphatase 1 modulates the subnuclear distribution of pre-mRNA splicing factors. Mol. Biol. Cell. 7:1996;1559-1572.
114. Misteli T., Caceres J.F., Clement J.Q., Krainer A.R., Wilkinson M.F., Spector D.L. Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo. J. Cell Biol. 143:1998;297-307.
115. Gomez-Munoz A., Duffy P.A., Martin A., O'Brien L., Byun H.S., Bittman R.et al. Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides. Mol. Pharmacol. 47:1995;833-839.
116. Lavie Y., Cao H., Bursten S.L., Giuliano A.E., Cabot M.C. Accumulation of glucosylceramides in multidrug-resistant cancer cells. J. Biol. Chem. 271:1996;19530-19536.
117. Schmelz E.M., Roberts P.C., Kustin E.M., Lemonnier L.A., Sullards M.C., Dillehay D.L.et al. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids. Cancer Res. 61:2001;6723-6729.
118. Pelled D., Raveh T., Riebeling C., Fridkin M., Berissi H., Futerman A.H.et al. Death-associated protein (DAP) kinase plays a central role in ceramide-induced apoptosis in cultured hippocampal neurons. J. Biol. Chem. 277:2002;1957-1961.
119. Kiley S.C., Jaken S., Whelan R., Parker P.J. Intracellular targeting of protein kinase C isoenzymes: functional implications. Biochem. Soc. Trans. 23:1995;601-605.
120. Newton A.C. Protein kinase C: structure, function, and regulation. J. Biol. Chem. 270:1995;28495-28498.
121. Dempsey E.C., Newton A.C., Mochly-Rosen D., Fields A.P., Reyland M.E., Insel P.A.et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am. J. Physiol. Lung Cell Mol. Physiol. 279:2000;L429-438.
122. Ruvolo P.P., Deng X., Carr B.K., May W.S. A functional role for mitochondrial PKC α in Bcl2 phosphorylation and suppression of apoptosis. J. Biol. Chem. 273:1998;25436-25442.
123. Johnson K.R., Becker K.P., Facchinetti M.M., Hannun Y.A., Obeid L.M. PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J. Biol. Chem. 277:2002;35257-35262.
124. Majumder P.K., Pandey P., Sun X., Cheng K., Datta R., Saxena S.et al. Mitochondrial translocation of protein kinase C delta in phorbol ester-induced cytochrome c release and apoptosis. J. Biol. Chem. 275:2000;21793-21796.
125. Majumder P.K., Mishra N.C., Sun X., Bharti A., Kharbanda S., Saxena S.et al. Targeting of protein kinase C delta to mitochondria in the oxidative stress response. Cell Growth Differ. 12:2001;465-470.
126. Sawai H., Okazaki T., Takeda Y., Tashima M., Sawada H., Okuma M.et al. Ceramide-induced translocation of protein kinase C-delta and -epsilon to the cytosol. Implications in apoptosis. J. Biol. Chem. 272:1997;2452-2458.
127. Signorelli P., Luberto C., Hannun Y.A. Ceramide inhibition of NF-kappaB activation involves reverse translocation of classical protein kinase C (PKC) isoenzymes: requirement for kinase activity and carboxyl-terminal phosphorylation of PKC for the ceramide response. FASEB J. 15:2001;2401-2414.